- Home
- PMCB vs TTNP Comparison
PMCB vs TTNP Comparison
Compare PMCB & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- TTNP
- Stock Information
- Founded
- PMCB 1996
- TTNP 1991
- Country
- PMCB United States
- TTNP United States
- Employees
- PMCB N/A
- TTNP N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PMCB Health Care
- TTNP Health Care
- Exchange
- PMCB Nasdaq
- TTNP Nasdaq
- Market Cap
- PMCB 7.3M
- TTNP 5.9M
- IPO Year
- PMCB N/A
- TTNP 1996
- Fundamental
- Price
- PMCB $1.07
- TTNP $4.45
- Analyst Decision
- PMCB
- TTNP
- Analyst Count
- PMCB 0
- TTNP 0
- Target Price
- PMCB N/A
- TTNP N/A
- AVG Volume (30 Days)
- PMCB 11.9K
- TTNP 23.4K
- Earning Date
- PMCB 08-12-2025
- TTNP 08-14-2025
- Dividend Yield
- PMCB N/A
- TTNP N/A
- EPS Growth
- PMCB N/A
- TTNP N/A
- EPS
- PMCB 1.29
- TTNP N/A
- Revenue
- PMCB N/A
- TTNP N/A
- Revenue This Year
- PMCB N/A
- TTNP N/A
- Revenue Next Year
- PMCB N/A
- TTNP N/A
- P/E Ratio
- PMCB $0.86
- TTNP N/A
- Revenue Growth
- PMCB N/A
- TTNP N/A
- 52 Week Low
- PMCB $1.00
- TTNP $3.03
- 52 Week High
- PMCB $2.42
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- PMCB 53.12
- TTNP 51.17
- Support Level
- PMCB $1.00
- TTNP $4.21
- Resistance Level
- PMCB $1.07
- TTNP $4.65
- Average True Range (ATR)
- PMCB 0.05
- TTNP 0.20
- MACD
- PMCB 0.01
- TTNP -0.01
- Stochastic Oscillator
- PMCB 66.67
- TTNP 52.83
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.